MRSN vs UPST · rev $40.5M vs P/E 74, rev $672.9M
Mersana Therapeutics Inc (MRSN) versus Upstart Holdings Inc (UPST) — a side-by-side from cached financials, not a winner call.
Mersana Therapeutics Inc (MRSN) is a biotechnology company listed on NASDAQ.
Upstart Holdings Inc (UPST) is a credit services company listed on NASDAQ.
Latest reported MRSN revenue for 2024-12-31 was $40.5M. Net income was -$69.2M. Revenue was up 9.9% from 2023-12-31 to 2024-12-31. MRSN currently screens at market cap $145.4M.
Latest reported UPST revenue for 2026-06-30 was $672.9M. Net income was $9.9M. UPST currently screens at market cap $2.92B and trailing P/E 74.3.
MRSN currently screens at market cap $145.4M. UPST currently screens at market cap $2.92B and trailing P/E 74.3.
Not investment advice. Open the MRSN and UPST stock pages for the full models.
Not investment advice.